Avanos Medical Inc.
AVNS | NYSE
$24.99
+$0.01 (+0.04%)
At close: Jul 24, 2026, 4:03 PM ET
Market Data
Market Cap $1.17B
Enterprise Value $1.24B
Beta 1.57
Average Volume 1.09M
Shares Outstanding (Diluted) 46.4M
Shares Change YoY -0.85%
Institutional Ownership 96.90%
Exchange NYSE
ISIN US05350V1061
Price Performance
Price Change 1M 0.2%
Price Change 3M 1.1%
Price Change 6M 80.4%
Price Change YTD 123.5%
Price Change 1Y 122.1%
Price Change 3Y 10.8%
Price Change 5Y -28.0%
1M CAGR (ann.) 0.0%
1Y CAGR (ann.) 106.4%
5Y CAGR (ann.) -6.3%
All-Time CAGR -4.1%
Valuation
PE Ratio -16.66
Forward PE 20.18
PEG Ratio -0.39
Forward PEG -0.67
PS Ratio 1.64
Forward PS 1.60
PB Ratio 1.50
P/FCF Ratio 156.10
P/Adj. FCF Ratio -11,707.27
P/OCF Ratio 31.63
EV/Sales 1.74
EV/EBIT -21.44
EV/EBITDA -67.22
EV/FCF 165.80
Earnings Yield -6.0%
FCF Yield 0.6%
Adj. FCF Yield 0.0%
Financial Health
Net Debt $72.8M
Total Debt $138.4M
Cash & Short-Term Investments $65.6M
Total Assets $1.05B
Current Ratio 2.48
Quick Ratio 1.40
Debt / Equity Ratio 0.18
Debt / EBITDA -7.48
Debt / FCF 18.45
OCF / Debt 0.27
Interest Coverage -7.88
Altman Z-Score 2.31
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 48.5%
Operating Profit Margin -7.9%
EBITDA Margin -3.0%
Net Profit Margin -9.7%
FCF Margin 1.1%
Adj. FCF Margin 0.0%
SBC / Revenue 1.8%
SBC Impact (per share) -101.3%
Returns
Return on Assets -6.6%
Return on Equity -8.9%
Return on Invested Capital -6.0%
Return on Capital Employed -6.2%
Return on Tangible Assets -12.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 1.5%
Revenue CAGR 5Y 0.0%
Revenue CAGR 10Y -7.5%
EPS CAGR 3Y -2.3%
EPS CAGR 5Y -65.9%
EPS CAGR 10Y -62.2%
FCF CAGR 3Y -51.1%
FCF CAGR 5Y -14.6%
FCF CAGR 10Y -17.2%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 8
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 9, 2026
EPS Estimate (next Q) $0.16
EPS Growth Est (next Q) -5.9%
Revenue Est (next Q) $173M
Revenue Growth Est (next Q) -1.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $23
Price Target Upside -8.0%
Cash Flow
Operating Cash Flow $36.7M
Free Cash Flow $7.5M
Adj. Free Cash Flow $-100K
FCF Per Share $0.16
OCF Per Share $0.79
OCF/S Ratio 5.1%
Income Statement
Revenue $715.9M
Gross Profit $353.4M
Operating Income $-56.7M
EBITDA $-18.5M
Net Income $-69.4M
EPS (Diluted) -$1.50
Revenue / Employee $313.03K
Profit / Employee $-30.35K
Employees 2,287
Add to Watchlist
Select watchlists to add or remove AVNS